One-liner#

Distinguish hypertensive urgency (severely elevated BP without acute end-organ damage) from hypertensive emergency (end-organ damage requiring ED), then safely lower BP over hours to days in the office while addressing underlying causes and optimizing long-term control.

Quick nav#

Red flags / send to ED#

  • Neurologic: severe headache, altered mental status, focal deficits, seizure, visual changes (hypertensive encephalopathy, stroke, PRES)
  • Cardiac: chest pain, dyspnea, pulmonary edema (ACS, acute HF, aortic dissection)
  • Renal: oliguria, hematuria, rapidly rising creatinine (acute kidney injury)
  • Vascular: tearing chest/back pain, pulse deficits, BP differential between arms (aortic dissection)
  • Obstetric: pregnancy with severe HTN (preeclampsia/eclampsia—out of scope but recognize and transfer)
  • Fundoscopic: papilledema, flame hemorrhages, exudates (malignant hypertension)
  • BP >180/120 with ANY of the above = hypertensive emergency → ED

Key history#

Confirm the reading:

  • Proper technique: seated 5 min, back supported, feet flat, arm at heart level, appropriate cuff size
  • Repeat measurement after 5 minutes of rest
  • Check both arms if first encounter or concern for dissection

Characterize the presentation:

  • Asymptomatic vs symptomatic
  • Acute rise vs chronic severe HTN
  • Known hypertension history and baseline BP
  • Recent BP readings (home, pharmacy, prior visits)

Identify precipitants:

  • Medication non-adherence (most common cause)
  • Ran out of medications / insurance/cost issues
  • Recent medication changes or discontinuation
  • Dietary indiscretion (high salt)
  • Acute pain, anxiety, panic
  • Substance use: cocaine, amphetamines, phencyclidine
  • OTC medications: NSAIDs, decongestants (pseudoephedrine), diet pills
  • Herbal supplements: licorice, ephedra, ginseng
  • Withdrawal: alcohol, clonidine, beta-blockers

Screen for end-organ damage symptoms:

  • Neurologic: headache, vision changes, confusion, weakness, numbness
  • Cardiac: chest pain, dyspnea, orthopnea, palpitations
  • Renal: decreased urine output, hematuria, flank pain

Relevant history:

  • HTN duration and usual control
  • Current antihypertensive regimen and adherence
  • Prior hypertensive crises
  • Comorbidities: CKD, CAD, HF, stroke, diabetes
  • Secondary HTN history: OSA, renal artery stenosis, pheochromocytoma, primary aldosteronism

Focused exam#

  • Vitals: BP both arms (manual preferred for accuracy), HR, RR, O2 sat
  • General: distress level, diaphoresis, anxiety
  • Neurologic: mental status, cranial nerves, motor/sensory, gait (if safe)
  • Fundoscopic: papilledema, hemorrhages, exudates, AV nicking (if equipment/skill available)
  • Cardiac: JVD, S3/S4, murmurs (AR in dissection), displaced PMI
  • Pulmonary: crackles (pulmonary edema)
  • Abdominal: bruits (renal artery stenosis), pulsatile mass (AAA)
  • Extremities: peripheral pulses, edema

Differential (quick pattern recognition)#

Common/likely (outpatient)#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Medication non-adherence“Ran out,” “can’t afford,” “forgot”Known HTN; missed doses; no symptomsElevated BP; otherwise normal examRestart/reinforce meds; address barriers; observe in office
White coat hypertension“Always high at doctor”Normal home readings; anxious in officeElevated BP; no end-organ signsHome BP monitoring; ambulatory BP monitoring if uncertain
Pain-induced HTN“Hurts,” “in pain”Acute pain from any causeElevated BP normalizes when pain controlledTreat underlying pain; recheck BP
Anxiety/panic“Stressed,” “anxious,” “heart racing”Situational; hyperventilation; palpitationsTachycardia; elevated BP; no end-organ signsReassurance; recheck after calming; consider anxiolytic
Rebound HTN“Stopped my clonidine”Recent discontinuation of clonidine, beta-blockerElevated BP; tachycardia (beta-blocker withdrawal)Restart discontinued agent; taper properly
Substance-induced“Used cocaine,” “took diet pills”Recent stimulant use; decongestants; NSAIDsElevated BP; tachycardia; dilated pupils (stimulants)Supportive care; benzodiazepines for stimulant-induced

Can’t-miss / urgent#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Hypertensive encephalopathy“Worst headache,” “confused,” “can’t see right”Severe HTN + neurologic symptomsAltered mental status; papilledema; focal deficitsED now; IV antihypertensives; imaging
Acute stroke“Weak on one side,” “face drooping,” “can’t talk”Sudden focal deficits; severe HTNFocal neurologic deficits; asymmetric examED now; stroke protocol
Aortic dissection“Tearing pain,” “ripping,” “worst pain”Sudden severe chest/back pain; HTNBP differential between arms; new AR murmur; pulse deficitsED now; CT angiography
Acute coronary syndrome“Chest pressure,” “squeezing,” “can’t breathe”Chest pain with severe HTNDiaphoresis; S4; may have normal examED now; ECG; troponin
Acute pulmonary edema“Can’t breathe,” “drowning”Dyspnea; orthopnea; severe HTNCrackles; JVD; S3; hypoxiaED now; IV diuretics; oxygen
Acute kidney injury“Not urinating,” “blood in urine”Oliguria; hematuria; rising CrEdema; may have flank tendernessED if severe; urgent nephrology

Workup#

In-office (all patients with BP >180/120):

  • Confirm BP with proper technique; repeat after 5 minutes rest
  • ECG: LVH, ischemic changes, arrhythmia
  • Basic labs: BMP (Cr, K), UA (proteinuria, hematuria)

Additional based on presentation:

  • If chest pain: ECG; consider ED for troponin
  • If neurologic symptoms: ED for imaging
  • If new/worsening renal function: urgent nephrology referral

When to consider secondary HTN workup:

  • Resistant HTN (uncontrolled on 3+ agents including diuretic)
  • Onset before age 30 or after age 55
  • Sudden worsening of previously controlled HTN
  • Hypokalemia (primary aldosteronism)
  • Renal bruit, flash pulmonary edema, worsening renal function with ACE-I/ARB (renal artery stenosis)
  • Paroxysmal HTN with headache, palpitations, diaphoresis (pheochromocytoma)
  • OSA symptoms (snoring, daytime somnolence, witnessed apneas)

When NOT to do extensive workup:

  • Clear precipitant (non-adherence, pain, anxiety) with no end-organ symptoms
  • Known chronic severe HTN at baseline with no acute change
  • Asymptomatic with normal exam and labs

Initial management#

Hypertensive urgency (no end-organ damage):

  • Goal: reduce BP gradually over 24–48 hours (not minutes)
  • Rapid reduction can cause stroke, MI, or renal ischemia
  • Restart/adjust oral medications; observe in office 1–2 hours
  • Discharge target: BP trending down (any reduction) and <180/110; patient asymptomatic
  • Do NOT use sublingual nifedipine (unpredictable, dangerous drops)
  • Dialysis patients: coordinate with nephrology; may need urgent dialysis if volume overloaded

Hypertensive emergency (end-organ damage):

  • ED transfer for IV antihypertensives and monitoring
  • Do NOT attempt to manage in office

Address precipitants:

  • Restart missed medications
  • Treat pain, anxiety
  • Discontinue offending agents (NSAIDs, decongestants)
  • Substance use: supportive care; benzodiazepines for stimulant-induced

Management by diagnosis#

Hypertensive urgency (asymptomatic severe HTN)#

Education:

  • Very high blood pressure without symptoms is concerning but not an emergency
  • Goal is to lower BP safely over 1–2 days, not immediately
  • Taking medications consistently is the most important thing you can do
  • Untreated severe HTN increases risk of stroke, heart attack, kidney damage over time

Treatment:

Immediate office management:

  • Rest in quiet room for 15–30 minutes; recheck BP
  • If on medications: give usual dose if due, or add/increase agent
  • Observe 1–2 hours; recheck BP every 30 minutes
  • Discharge criteria: BP trending down AND <180/110 AND asymptomatic
  • If BP not improving after 2 hours or symptoms develop → ED

Oral agents for acute BP lowering (choose based on comorbidities):

DrugDoseContraindicationsMonitoringCostNotes
Clonidine0.1–0.2 mg PO; may repeat in 1 hour (max 0.6 mg)Bradycardia; AV blockHR, BP, sedation$Rapid onset (30–60 min); causes sedation; must taper to discontinue
Captopril25 mg PO; may repeat in 1–2 hoursAngioedema; bilateral RAS; pregnancy; K >5.5BP, Cr, K$Onset 15–30 min; avoid if volume depleted
Labetalol200–400 mg POSevere bradycardia; AV block; asthma; decompensated HFHR, BP$Onset 1–2 hours; good if tachycardic
Amlodipine5–10 mg POSevere AS; hypotensionBP, HR, edema$Slow onset (6–12 hours); better for long-term adjustment
Hydralazine25 mg PO; may repeat in 4–6 hoursCAD (reflex tachycardia); SLEHR, BP$Causes reflex tachycardia; pair with beta-blocker

Long-term optimization (adjust regimen for sustained control):

DrugDoseContraindicationsMonitoringCostNotes
Lisinopril10–40 mg dailyAngioedema; bilateral RAS; pregnancyCr, K at 1–2 weeks$First-line; especially if DM, CKD, HF
Amlodipine5–10 mg dailySevere ASBP; ankle edema$First-line; good for elderly, Black patients
Chlorthalidone12.5–25 mg dailyGout; severe hypokalemiaK, Na, Cr, uric acid$Preferred thiazide-like; more potent than HCTZ
Losartan50–100 mg dailySame as ACE-ICr, K$ARB if ACE-I cough; less angioedema risk
Metoprolol succinate25–200 mg dailySevere bradycardia; decompensated HF; asthmaHR, BP$Add if CAD, HF, tachycardia
Spironolactone25–50 mg dailyK >5.0; severe CKDK, Cr$Add-on for resistant HTN; check K closely

Follow-up: 1 week for BP recheck and medication adjustment; sooner if symptoms develop.

Addressing cost/access barriers:

  • Many antihypertensives are $4/month at major pharmacies (lisinopril, amlodipine, metoprolol, HCTZ)
  • Patient assistance programs: manufacturer programs for brand-name drugs; NeedyMeds.org, RxAssist.org
  • 90-day supplies often cheaper than monthly
  • If cost is barrier, prioritize: thiazide + ACE-I/ARB or CCB (all generic, cheap)

Rebound hypertension (clonidine/beta-blocker withdrawal)#

Education:

  • Stopping certain BP medications suddenly can cause dangerous rebound high blood pressure
  • Clonidine and beta-blockers must be tapered, not stopped abruptly
  • If you run out, call for refill immediately; don’t just skip doses

Treatment:

Clonidine withdrawal:

  • Restart clonidine immediately: 0.1–0.2 mg PO
  • May repeat in 1 hour if needed
  • Once stabilized, taper over 1–2 weeks (reduce by 0.1 mg every 3–7 days)
  • Consider transitioning to longer-acting agent

Beta-blocker withdrawal:

  • Restart beta-blocker at previous dose
  • If unavailable, use labetalol or another beta-blocker
  • Taper over 1–2 weeks when discontinuing

Follow-up: 2–3 days to ensure BP controlled; plan taper schedule.


Stimulant-induced hypertension (cocaine, amphetamines)#

Education:

  • Stimulants cause blood vessels to constrict and heart to race, raising BP dangerously
  • Effects usually wear off in hours, but can cause stroke or heart attack
  • Avoid stimulants; if using, this is a sign to seek help

Treatment:

Acute management:

  • Benzodiazepines first-line (reduce sympathetic drive)
  • Avoid beta-blockers alone (unopposed alpha stimulation can worsen HTN)
  • If beta-blockade needed, use labetalol (combined alpha/beta) or add alpha-blocker first
DrugDoseContraindicationsMonitoringCostNotes
Lorazepam1–2 mg PO/IMRespiratory depressionSedation, RR$First-line for stimulant-induced HTN
Diazepam5–10 mg POSameSame$Alternative benzodiazepine
Labetalol200 mg POSevere bradycardia; asthmaHR, BP$If beta-blockade needed; has alpha-blocking activity
Phentolamine5 mg IVHypotensionBP$$Alpha-blocker; ED setting only

If severe or not responding:

  • ED transfer for IV management and monitoring
  • Cardiology consult if chest pain or ECG changes

Follow-up: 24–48 hours if managed as outpatient; substance use counseling referral.


White coat hypertension#

Education:

  • Blood pressure is high in the office but normal at home
  • This is common and doesn’t always need medication
  • Home monitoring helps us know your true BP

Treatment:

Diagnosis:

  • Home BP monitoring: average of readings over 1–2 weeks
  • Ambulatory BP monitoring (ABPM): gold standard; 24-hour average
  • White coat HTN: office BP ≥130/80 but home/ABPM <130/80

Management:

  • If confirmed white coat HTN: lifestyle modifications, no medications
  • Monitor annually; ~15–30% progress to sustained HTN
  • Treat if home BP becomes elevated

Follow-up: 3–6 months with home BP log; annual reassessment.


Resistant hypertension#

Education:

  • Blood pressure remains high despite taking 3 or more medications
  • Often there’s an underlying cause we can find and treat
  • Medication adherence and lifestyle are still critical

Treatment:

Confirm true resistance:

  • Verify adherence (pill counts, pharmacy records, direct questioning)
  • Confirm proper BP measurement technique
  • Rule out white coat effect with home/ambulatory monitoring
  • Review for interfering substances (NSAIDs, decongestants, alcohol, licorice)

Optimize current regimen:

  • Ensure includes diuretic at adequate dose (chlorthalidone preferred)
  • Maximize doses before adding agents
  • Consider timing (some agents better at night)

Add-on therapy:

DrugDoseContraindicationsMonitoringCostNotes
Spironolactone25–50 mg dailyK >5.0; eGFR <30K, Cr at 1 week, then monthly$Most effective add-on for resistant HTN
Eplerenone50–100 mg dailySameSame$$Alternative if gynecomastia with spironolactone
Clonidine0.1 mg BID–TID or patch 0.1–0.3 mg/weekBradycardiaHR, sedation$Central agent; sedation, rebound risk
Hydralazine25–100 mg TIDCAD (reflex tachycardia)HR, BP$Direct vasodilator; causes reflex tachycardia
Minoxidil5–40 mg dailyPheochromocytomaHR, fluid retention$Potent; causes fluid retention and hirsutism

Secondary HTN workup:

  • Primary aldosteronism: aldosterone/renin ratio (hold interfering meds)
  • Renal artery stenosis: renal artery duplex or CTA/MRA
  • Pheochromocytoma: plasma metanephrines
  • OSA: sleep study
  • Thyroid: TSH
  • Cushing’s: 24-hour urine cortisol or overnight dexamethasone suppression

Follow-up: 2–4 weeks after medication changes; coordinate with hypertension specialist or nephrology for resistant cases.

Follow-up#

  • Hypertensive urgency: 1 week for BP recheck; adjust medications as needed
  • Rebound HTN: 2–3 days; plan taper
  • Stimulant-induced: 24–48 hours; substance use referral
  • White coat HTN: 3–6 months with home BP log
  • Resistant HTN: 2–4 weeks; consider specialist referral

Return precautions (all patients):

  • Severe headache, especially “worst headache of life”
  • Vision changes, confusion, difficulty speaking
  • Chest pain or shortness of breath
  • Weakness or numbness on one side
  • Nausea/vomiting with headache

Patient instructions#

  • Take your blood pressure medications every day, even if you feel fine.
  • If you run out of medication, call us immediately for a refill—do not skip doses.
  • Check your blood pressure at home if you have a monitor; bring the readings to your appointments.
  • Reduce salt in your diet; avoid adding salt and limit processed foods.
  • Avoid medications that raise blood pressure: ibuprofen, naproxen, decongestants (pseudoephedrine).
  • Limit alcohol and avoid cocaine or other stimulants.
  • Call or seek care immediately if you develop severe headache, vision changes, chest pain, shortness of breath, or weakness on one side of your body.

Smartphrase snippets#

  • Hypertensive urgency, asymptomatic: BP [X/Y] in office. No headache, vision changes, chest pain, or dyspnea. Exam without focal deficits, papilledema, or pulmonary edema. ECG: [normal/LVH]. Cr [X]. Likely [non-adherence/medication adjustment needed]. Restarted/adjusted [medication]. Observed in office with BP improving to [X/Y]. Discussed adherence, return precautions. Follow-up 1 week.

  • Hypertensive urgency, medication non-adherence: BP [X/Y]. Patient reports missing [medication] for [duration] due to [reason]. No end-organ symptoms. Restarted [medication]. Addressed barriers to adherence. BP improved to [X/Y] after observation. Return precautions reviewed.

  • Elevated BP, white coat effect suspected: Office BP [X/Y] but patient reports normal home readings. No end-organ symptoms. Plan: home BP monitoring x 2 weeks with log. If persistently elevated at home, will initiate/adjust therapy. If normal, will monitor annually.

Coding/billing notes#

  • Document BP measurement technique and repeat readings
  • Document symptom review for end-organ damage (headache, vision, chest pain, dyspnea, neuro symptoms)
  • Document exam findings relevant to end-organ assessment
  • If not sending to ED, document rationale (no end-organ symptoms/signs, improving with observation)
  • Document adherence assessment and barriers identified
  • For resistant HTN, document current regimen and adherence verification

Complaint pages#

Problem pages#